80 related articles for article (PubMed ID: 18999897)
1. Apobec 3F and apobec 3G have no inhibition and hypermutation effect on the human influenza A virus.
Wang GF; Lin SY; Zhang H; Gao YL; Li WZ; Xin G; Li KS
Acta Virol; 2008; 52(3):193-4. PubMed ID: 18999897
[No Abstract] [Full Text] [Related]
2. High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity.
Pauli EK; Schmolke M; Hofmann H; Ehrhardt C; Flory E; Münk C; Ludwig S
Retrovirology; 2009 Apr; 6():38. PubMed ID: 19371434
[TBL] [Abstract][Full Text] [Related]
3. Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.
Jost S; Turelli P; Mangeat B; Protzer U; Trono D
J Virol; 2007 Oct; 81(19):10588-96. PubMed ID: 17652382
[TBL] [Abstract][Full Text] [Related]
4. Restriction of retroviral replication by APOBEC3G/F and TRIM5alpha.
Huthoff H; Towers GJ
Trends Microbiol; 2008 Dec; 16(12):612-9. PubMed ID: 18976920
[TBL] [Abstract][Full Text] [Related]
5. HIV-2 Vif Diversity Among Defective and Nondefective Sequences.
Bertine M; Visseaux B; Storto A; Collin G; Matheron S; Descamps D; Charpentier C;
J Acquir Immune Defic Syndr; 2016 May; 72(1):e9-e11. PubMed ID: 26689972
[No Abstract] [Full Text] [Related]
6. Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins.
Wiegand HL; Cullen BR
J Virol; 2007 Dec; 81(24):13694-9. PubMed ID: 17913830
[TBL] [Abstract][Full Text] [Related]
7. Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo.
Suspène R; Guétard D; Henry M; Sommer P; Wain-Hobson S; Vartanian JP
Proc Natl Acad Sci U S A; 2005 Jun; 102(23):8321-6. PubMed ID: 15919829
[TBL] [Abstract][Full Text] [Related]
8. APOBEC-mediated editing of viral RNA.
Bishop KN; Holmes RK; Sheehy AM; Malim MH
Science; 2004 Jul; 305(5684):645. PubMed ID: 15286366
[TBL] [Abstract][Full Text] [Related]
9. Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV.
Stieler K; Fischer N
PLoS One; 2010 Jul; 5(7):e11738. PubMed ID: 20668529
[TBL] [Abstract][Full Text] [Related]
10. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
[TBL] [Abstract][Full Text] [Related]
11. Guanine-adenine bias: a general property of retroid viruses that is unrelated to host-induced hypermutation.
Müller V; Bonhoeffer S
Trends Genet; 2005 May; 21(5):264-8. PubMed ID: 15851060
[TBL] [Abstract][Full Text] [Related]
12. Replication potentials of vif variant viruses generated from monkey cell-tropic HIV-1 derivative clones NL-DT5/NL-DT5R.
Hatcho K; Kamada K; Yamashita T; Adachi A; Nomaguchi M
Microbes Infect; 2008; 10(10-11):1218-22. PubMed ID: 18617010
[TBL] [Abstract][Full Text] [Related]
13. Status of APOBEC3G/F in cells and progeny virions modulated by Vif determines HIV-1 infectivity.
Yamashita T; Nomaguchi M; Miyake A; Uchiyama T; Adachi A
Microbes Infect; 2010 Feb; 12(2):166-71. PubMed ID: 19944180
[TBL] [Abstract][Full Text] [Related]
14. Retroviral restriction by APOBEC proteins.
Harris RS; Liddament MT
Nat Rev Immunol; 2004 Nov; 4(11):868-77. PubMed ID: 15516966
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of Alu retrotransposition by APOBEC3G.
Hulme AE; Bogerd HP; Cullen BR; Moran JV
Gene; 2007 Apr; 390(1-2):199-205. PubMed ID: 17079095
[TBL] [Abstract][Full Text] [Related]
16. A high rate of polymerization during synthesis of mouse mammary tumor virus DNA alleviates hypermutation by APOBEC3 proteins.
Hagen B; Kraase M; Indikova I; Indik S
PLoS Pathog; 2019 Feb; 15(2):e1007533. PubMed ID: 30768644
[TBL] [Abstract][Full Text] [Related]
17. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
Langlois MA; Beale RC; Conticello SG; Neuberger MS
Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
[TBL] [Abstract][Full Text] [Related]
18. Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.
Miyagi E; Opi S; Takeuchi H; Khan M; Goila-Gaur R; Kao S; Strebel K
J Virol; 2007 Dec; 81(24):13346-53. PubMed ID: 17928335
[TBL] [Abstract][Full Text] [Related]
19. Further investigation of simian immunodeficiency virus Vif function in human cells.
Gaddis NC; Sheehy AM; Ahmad KM; Swanson CM; Bishop KN; Beer BE; Marx PA; Gao F; Bibollet-Ruche F; Hahn BH; Malim MH
J Virol; 2004 Nov; 78(21):12041-6. PubMed ID: 15479843
[TBL] [Abstract][Full Text] [Related]
20. Enhancing immunity to HIV through APOBEC.
Harris RS
Nat Biotechnol; 2008 Oct; 26(10):1089-90. PubMed ID: 18846074
[No Abstract] [Full Text] [Related]
[Next] [New Search]
